bio plex tm suspension array reader (Bio-Rad)

Bio-Rad is a verified supplier

Bio-Rad manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Bio-Rad bio plex tm suspension array reader
Bio Plex Tm Suspension Array Reader, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 72 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bio+plex+tm+suspension+array+reader/Bio-Rad+ANA+Screening+Test/pmc07679981-293-27-32
Average 93 stars, based on 72 article reviews

bio plex tm suspension array reader - by Bioz Stars, 2026-11

93/100 stars

Images

Diagnostic Assay:

Article Title: Hemoglobin Variant Analysis and Its Comparison between Conventional High-performance Liquid Chromatography Using Whole Blood versus Dried Blood Spot: High-performance Liquid Chromatography.
Article Snippet: .. [16] Given these facts, the present study aims to evaluate DBS‐HPLC as a one‐step screening cum diagnostic test for all clinically relevant hemoglobinopathies, and compare it to the conventional WB – HPLC (Bio‐Rad Variant‐II) testing for children and adults. ..

Western Blot:

High Performance Liquid Chromatography:

Variant Assay:

Isolation:

Article Title: Identification of plasmid-mediated tigecycline resistance tet (x4) and New Delhi metallo-β-lactamase (NDM) in an Escherichia coli isolate from Canada
Article Snippet: .. Routine admission screening for carbapenemase-producing organisms was performed by direct plating of a pooled nasal/rectal swab onto extended-spectrum β-lactamase isolation media (Oxoid), followed by meropenem disk diffusion screening and a β-CARB test (Bio-Rad). .. An E. coli isolate confirmed by PCR (Xpert CarbaR, Cepheid) to harbor bla NDM and bla OXA-48-type was recovered and sent to the National Microbiology Laboratory, where antimicrobial susceptibility testing by Sensititre and whole genome sequencing using both the Illumina NextSeq Platform (Illumina, San Diego, USA) and Oxford Nanopore Technologies (ONT) (Oxford, Oxfordshire, UK) Minion platform were performed.

Diffusion-based Assay:

Clinical Proteomics:

Article Title: Analysis of Titers of Immunoglobulin M and Immunoglobulin G ABO Antibodies in Group O Blood and Plateletphersis Donors at a Tertiary Care Hospital.
Article Snippet: Context: ABO isoagglutinins, particularly anti‐A and anti‐B antibodies, are clinically significant in transfusion medicine due to their potential to cause hemolytic reactions in recipients of ABO‐incompatible blood components.. Evaluating the distribution of isoagglutinin titers in group O donors is essential for enhancing transfusion safety.. Aims: The aim of this study was to assess and compare anti‐A and anti‐B immunoglobulin (Ig) M and IgG titers among group O whole blood and plateletpheresis donors and explore their association with donor age and type.

Article Title:
Article Snippet: The ANA Screen is intended for use with the Bio-Rad BioPlex 2200 System. .. Indication(s) for use: The Bio-Rad ANA Screen is intended for the qualitative screening of specific antinuclear antibodies (ANA), the quantitative detection of antibody to dsDNA, and the semi-quantitative detection of ten (10) separate antibody assays (Chromatin, Ribosomal Protein, SS-A, SS-B, Sm, Sm/RNP, RNP, Scl70, Jo-1, and Centromere B,) in human serum and/or EDTA or heparinized plasma. ..

Agglutination:

Article Title: ISBT and ANZSBT abstracts of the joint Blood2025-ISBT 36th Regional Congress, Perth, Australia, 26-29 October 2025.
Article Snippet: Medicinal products derived from human blood and plasma donations are essential to healthcare worldwide.. In 2010, the World Health Assembly adopted resolution WHA 63.12, urging Member States to establish, implement, and support nationally coordinated, well-managed, and sustainable blood and plasma programs to achieve self-sufficiency.. To monitor the global availability, safety, and accessibility of blood for transfusion, the World Health Organization (WHO) launched the Global Database on Blood Safety (GDBS) in 1998.

Comparison:

Article Title:
Article Snippet: .. Comparison of BioPlex 2200 ANA Screen (Qualitative Screening Format) to Bio-Rad (Helix) Autoimmune EIA ANA Screening Test in Patients with Physician Diagnosed Targeted CTD (n=413): BioPlex 2200 ANA Screen Bio-Rad (Helix) EIA Positive Negative Total Positive 256 76 332 Negative 9 72 81 Total 265 148 413 Positive Agreement: 77.1% (256/332) Negative Agreement: 88.9% (72/81) Overall Agreement 79.4% (328/413) Comparison of BioPlex 2200 ANA Screen (Qualitative Screening Format) to Bio-Rad (Helix) Autoimmune EIA ANA Screening Test in Patients with Criteria Diagnosed Targeted CTD (n=408): BioPlex 2200 ANA Screen Bio-Rad (Helix) EIA Positive Negative Total Positive 268 67 335 Negative 9 64 73 Total 277 131 408 Positive Agreement: 80.0% (268/335) Negative Agreement: 87.7% (64/73) Overall Agreement 81.4% (332/408) Comparison of Selected Antibodies to EIA Methods (n=1047): Testing to evaluate the performance of the BioPlex 2200 ANA Screen compared to the individual predicate EIAs was conducted at three sites located in the U.S. using 907 samples collected prospectively from consecutive patients being seen in a rheumatology clinic and suspected of, or with a history consistent with an autoimmune/connective tissue disease. .. Additional selected retrospective (frozen) samples, known to be positive for one or more of the 11 analytes detected by the Bio-Rad BioPlex 2200 ANA Screen were selected for inclusion in the study.

Article Title:
Article Snippet: .. Method comparison with predicate devices: Comparison of ANA Screen and ANA Microplate EIA Screen: The ability of BioPlex 2200 System ANA Screen qualitative screening format to detect positive results in serum samples collected prospectively from patients was compared to results of testing with the Bio-Rad (Helix) Autoimmune EIA ANA Screening test. ..

Review